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Placental invasionAbstract Purpose: To highlight the role of ultrasound (US) and magnetic resonance imaging
(MRI) in detecting placental abnormalities and diseases.
Patients and methods: This prospective study included fifty pregnant females with placental abnor-
malities (40 patients with abnormal placental location and/or implantation and 10 patients with
other variable placental abnormalities). All the patients underwent US and MRI examination
and detailed assessment of the placenta was performed. Operative findings, histopathology and/
or follow-up were the gold standard for diagnosis in all cases.
Results: The cases statistically evaluated in this study were gravid females with placenta previa at
high risk of coexisting placental adhesive disorders (n= 39/50). The sensitivity and specificity of
USwere 68% and 78.57% respectively while those ofMRIwere 80% and 85.71% respectively in their
ability to diagnose placental invasion. In placental hematoma cases,MRI confirmed the diagnosis due
to the high sensitivity and specificity of MRI in detecting different ages of blood. In cases of molar
pregnancy presence/absence of myometrial invasion was correctly detected in all cases by MRI.
Conclusion: Magnetic resonance imaging is complementary toUltrasound and it is important for the
accurate diagnosis of placental abnormalities especially placenta previa and the seriously co-existing
placenta accreta.
 2016 The Egyptian Society of Radiology andNuclearMedicine. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).1. Introduction
The placenta is an organ that develops during pregnancy in the
uterus. It receives attention only when an abnormality isdetected. Abnormalities of the placenta are important to rec-
ognize owing to the potential for maternal and fetal morbidity
and mortality (1).
Pathologic conditions of the placenta include placental
causes of hemorrhage, gestational trophoblastic disease, non-
trophoblastic placental tumors, metastases and cystic lesions
(1). Placental abruption, placenta previa, morbidly adherent
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the common placental causes of hemorrhage (2).
Antepartum imaging should be performed with minimal
risk to both the mother and developing fetus. Therefore, non-
invasive techniques that do not use ionizing radiation such as
ultrasonography (US) and magnetic resonance (MR) imaging
are preferred (1).
Sonography is the first imaging modality for evaluation of
the placenta in the antepartum period. Color and power Dop-
pler techniques permit visualization of placental vascularity,
allowing direct assessment of both the uteroplacental and feto-
placental circulations (3).
MR imaging has many unique properties that make it well-
suited for imaging of the placenta and is the other dominant
imaging modality in the antepartum period (4).
So the aim of this study was to highlight the role of ultra-
sound (US) and magnetic resonance imaging (MRI) in detect-
ing placental abnormalities and diseases.
2. Patients and methods
2.1. Patients
The current study had been approved by Kasr El-Aini Hospi-
tal, Research and Ethical committee, Cairo University; all the
included cases gave informed consent.
The study included 50 pregnant females (age range: 20–40
+ mean 30.58). Those patients were found to have placental
abnormalities and diseases (abnormal placental location and/
or implantation, gestational trophoblastic disease and hema-
toma/abruption) at antepartum Ultrasound.
The majority of the cases (n= 39/50) were at high risk for
placental invasion regarding their clinical history of either one
or all of the following in addition to the major co-existing fac-
tor which is placenta previa (n= 39/39): (1) maternal age
>35 years (n= 9/39), (2) grand multiparity (n= 3/39), (3)
previous uterine interventional procedures (e.g. cesarean sec-
tions, dilatation and curettage and Myomectomy)
(n= 38/39). Their ages ranged from 20 to 39 years (mean
age: 30.69 years).
2.2. Methods
All cases (n= 50/50) were subjected to both Ultrasound (US)
and Magnetic Resonance Imaging (MRI) of the pelvis.
2.2.1. Ultrasound examination
Scanning was performed using LOGIQ 7 PRO, GE (General
electric medical system) ultrasound machine:
(1) Transabdominal approach (gray scale and color/power
Doppler) using 3–5 MHz sector transducer.
(2) Transvaginal and translabial approach (gray scale and
color/power Doppler) using 7–8 MHz endoluminal
transducer was performed to assess the interface
between the myometrium and the urinary bladder espe-
cially when it was not clear due to obesity and/or inad-
equate bladder filling.2.2.2. Magnetic resonance imaging
MRI was performed for all cases using a 1.5-T (Gyroscan
Intera, Philips medical systems, the Netherlands). They were
imaged in the supine position using phased-array pelvic coil.
MRI evaluation of the placenta without the use of gadolin-
ium was performed in 42 patients (n= 42/50): 39 patients with
placenta previa to provide more accurate diagnosis of its loca-
tion, type of previa and to look for MRI signs of placental
invasion, 1 patient with CS scar pregnancy and 2 patients with
suspected hematoma and abruption. This is the approach most
suitable for gravid patients since the European Medicines
Agency warns against the use of gadolinium before the first
year of life (5).
The maternal pelvis was scanned using the following
protocol:
(1) T2-weighted pulse sequence-fast spin echo (FSE): TE
90 ms, TR 5000 ms in the axial, sagittal and coronal
planes using matrix 256  192.
(2) T1-weighted sequence-spin echo (SE): TE 15 ms, TR
535 ms in the axial, sagittal and coronal planes.
(3) Balanced fast field echo (B-FFE): TE 1 ms, TR 3 ms in
the sagittal and coronal planes using matrix 384  192.
(4) T2 Single Shot spin echo (SSh-SE): TE 309 ms, TR
15,000 ms in the sagittal plane.
Slice thickness = 5–6 mm with 1 mm gap, flip angle = 90
and FOV= 370–400 mm.
Sequences (1,2) were performed with respiratory triggering
to control maternal and fetal motion artifacts.
Scanning time was 32 min, and no intravenous injection of
gadolinium was used in these cases.
MRI of the pelvis with intravenous injection of gadolinium
(magnevist) at a dose of 0.1 mmol/kg was performed in 8
patients (n= 8/50) with suspected gestational trophoblastic
disease, using the following protocol:
(1) T2-weighted pulse sequence-fast spin echo (FSE): TE
90 ms, TR 3100 ms in the axial, sagittal and coronal
planes.
(2) T1-weighted sequence-spin echo (SE): TE 10 ms, TR
422 ms in the axial, sagittal and coronal planes.
(3) T1-weighted sequence-spin echo (SE) post contrast: TE
10 ms, TR 422 ms in the axial, sagittal and coronal
planes.
Slice thickness = 5–6.5 mm with 1 mm gap, flip angle = 90
and FOV= 280–350 mm.
2.3. Image analysis
Ultrasound analysis (transabdominal and/or transvaginal and
translabial approach) was performed by qualified physicians of
Obstetrics and Gynecology and/or Radiology and MRI analy-
sis was performed by 2 qualified consultants of Radiology and
the higher suggestion was taken in consideration.
Following Elsayes et al. (1) placenta previa was subdivided
according to the position of the placenta relative to the internal
cervical os into low-lying, marginal, complete, and central.
Table 1 Final US and final diagnosis cross tabulation in
placenta previa patients.
Count Final diagnosis Total
Negative Positive
Final US
Negative 11 8 19
Positive 3 17 20
Total 14 25 39
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previa findings that were considered suggestive of placental
invasion on US included loss of the retroplacental hypoechoic
clear zone, loss of the bladder wall-uterine interface, presence
of placental lacunae (vascular spaces), and presence of hyper-
vascularity of the interface between the uterine serosa and the
bladder wall on color Doppler imaging.
Following Baughman et al. (8) findings that were consid-
ered suggestive of placental invasion on MRI in addition to
previa, included uterine bulging, heterogeneous signal intensity
within the placenta, dark intraplacental bands on T2-WI, focal
interruptions in the myometrial wall, tenting of the bladder,
and direct visualization of the invasion of pelvic structures
by placental tissue.
According to the imaging suggestion of the degree of previa
and absence/presence of invasion, delivery plan was made.
Findings at the cesarean section and/or pathological results
were considered the gold standard of reference.
2.4. Statistics
The cases statistically evaluated in this study were only those
with placenta previa at high risk of coexisting placental adhe-
sive disorders (n= 39/50). Data were statistically described in
terms of mean ± standard deviation (±SD), median and
range, or frequencies (number of cases) and percentages when
appropriate. For comparing categorical data, Chi square (v2)
test was performed. Accuracy was represented using the terms
sensitivity, specificity, positive predictive value, negative pre-
dictive value, overall accuracy, positive likelihood ratio and
negative likelihood ratio. P values less than 0.05 were consid-
ered statistically significant. All statistical calculations were
done using computer programs SPSS (Statistical Package for
the Social Science; SPSS Inc., Chicago, IL, USA) version 15
for Microsoft Windows.
2.4.1. Accuracy calculations
Sensitivity = True positive  [True positive + False
negative].
Specificity = True negative  [True negative + False
positive].
Positive predictive value = True positive  [True positive
+ False positive].
Negative predictive value = True negative  [True nega-
tive + False negative].
Overall accuracy = [True positive + True negative]  All
sample.
Positive likelihood ratio = sensitivity  [1-specificity].
Negative likelihood ratio = [1-sensitivity]  specificity.
3. Results
The current study included 50 cases of placental abnormalities
and diseases: among which 40 had abnormal placental location
and/or implantation (39 were placenta previa at high risk of
coexisting placental adhesive disorders and one was ectopic
pregnancy on cesarean section scar with evidence of decidual
invasion). The other 10 cases had variable placental abnormal-ities (4 choriocarcinoma, 4 vesicular mole, 2 hematoma and
abruption).
We divided the cases into 3 different groups based on imag-
ing (US and MRI), operative, pathologic findings and/or
follow-up:
 Group I (n= 40/50, 80%): Abnormal placental location
and/or implantation.
 Group II (n= 8/50, 16%): Gestational trophoblastic dis-
ease; choriocarcinoma, invasive mole and vesicular mole.
 Group III (n= 2/50, 4%): Placental hematoma and
abruption.3.1. Results for group I (Abnormal placental location and/or
implantation)
Among this group one case was ectopic pregnancy (diagnosed
by empty uterine cavity on US and MRI) at 10 weeks GA
where the embryo was implanted on the CS scar with ectopic
decidual invasion at the scar site (diagnosed by MRI). The
patient had history of previous 5 CS.
The rest of cases (39/40 cases) in this group were gravid
females with placenta previa. Their mean age was 30.69 years
±SD and their gestational age ranged from 25 to 37 weeks.
Among the 39 cases, placenta previa was found to be cen-
tral in 23/39 cases (58.97%), complete in 12/39 cases
(30.77%), marginalis in 2/39 cases (5.15%) and low lying in
2/39 cases (5.15%). History of prior uterine surgery was eli-
cited in 38/39 cases (97.44%).
Twenty-five of these 39 patients (64.1%) had a diagnosis of
placental invasion clinically at delivery, by pathologic exami-
nation, or both. All of these patients had previous uterine
surgeries.
Among the 25 cases proved to have placental invasion, 9/25
had placenta accreta (36%), 9/25 had placenta percreta (36%)
and 7/25 had placenta increta (28%). Most of these cases
(n= 23/25, 92%) underwent cesarean hysterectomy following
delivery, and one of them had partial cystectomy as well. The
other 2 (8%) cases had manual separation of the placenta with
methotrexate afterward.
Cases diagnosed as placenta previa with no myometrial
invasion were 14 cases. History of previous uterine surgeries
was elicited in 13/14 cases (92.9%).
Ultrasound and MRI examination were done for all the
thirty-nine patients between 25 and 37 weeks gestational age.
The diagnostic performance of US and MRI in 39 patients
with placenta previa is shown in Tables 1–3, with detailed US
Table 2 Final MRI and final diagnosis cross tabulation in
placenta previa patients.
Count Final diagnosis Total
Negative Positive
Final MRI
Negative 12 5 17
Positive 2 20 22
Total 14 25 39
Table 3 The diagnostic performance of US and MRI in
placenta previa patients.
Items US MRI
Previa/invasion 20/39 22/39
Previa/no invasion 19/39 17/39
True positive 17 20
False positive 3 2
True negative 11 12
False negative 8 5
Sensitivity 68.00 80.00
Specificity 78.57 85.71
Positive predictive value 85.00 90.91
Negative predictive value 57.89 70.59
Accuracy 71.79 82.05
Positive likelihood ratio/95%
confidence interval
3.17/1.12–
8.96
5.60/1.53–
20.5
Negative likelihood ratio/95%
confidence interval
0.41/0.22–
0.75
0.23/0.10–
0.52
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cental invasion in Tables 4–7. The diagnostic accuracy of
MRI was statistically higher than US, P value = 0.002.
Concerning the imaging criteria of abnormal placental
implantation, multiple findings were more common than a sin-
gle isolated finding. The US and MRI findings in proved cases
of placental invasion are shown in Tables 8 and 9 respectively.
Matching between US and MRI findings was found in
78.57% (n= 11/14) of the negative cases (Fig. 1) and in
68% (n= 17/25) of the positive cases (Figs. 2 and 3) for pla-
cental invasion.
Out of the 25 cases proved to have placental invasion, 16/25
cases (64%) had placenta accreta/increta and 9/25 cases (36%)
had placenta percreta.
US correctly suggested the diagnosis of percreta in 6/9 cases
(66.7%) where interruption of the posterior bladder wall-
uterine interface and presence of hypervascularity of the inter-
face between uterine serosa and bladder wall on color Doppler
were seen and MRI correctly suggested the diagnosis of perc-
reta also in 6/9 cases (66.67%) where direct visualization of
invasion of the pelvis structures was seen (Table 10).
US underestimated 2 cases of percreta and overestimated 1
case as percreta, on the other hand MRI underestimated 2
cases of percreta. Both modalities failed to diagnose one case
of percreta posteriorly where the placenta was extending out-
side the uterus invading the surrounding fat posteriorly.3.2. Results for group II (Gestational trophoblastic disease)
Eight cases were diagnosed with gestational trophoblastic dis-
ease. Their ages ranged between 24 and 40 years. They pre-
sented with 1st trimester vaginal bleeding. Four were found
to be vesicular mole (two complete and two partial) and 4 were
found to have invasive mole/choriocarcinoma based on the
follow-up bHCG and/or pathological results.
Using US, 5 cases were diagnosed as vesicular mole (4 were
correctly diagnosed (Fig. 9), one was found out to be chorio-
carcinoma/invasive mole (Fig. 10)) due to the presence of
highly vascular echogenic masses with cystic changes, ovarian
cysts and no myometrial invasion, the other 3 were correctly
diagnosed as choriocarcinoma/invasive mole. However the
presence of myometrial invasion detected by MRI in 4 cases
helped to correctly suggest the diagnosis of choriocarcinoma/
invasive mole in the 4 cases.
3.3. Results for group III (Retroplacental hematoma and
abruption)
Two cases had placental hematoma, US helped to diagnose
one of them due to the presence of avascular mass while the
other one was suspected to be a placental mass (Fig. 11).
MRI confirmed the diagnosis of the 2 cases and showed the
retroplacental separation (abruption) in the former case and
this is due to the high sensitivity and specificity of MRI to
detect different ages of blood.
4. Discussion
Imaging of the placenta can have a significant impact on
patient management, owing to the morbidity and mortality
associated with various placental conditions (9).
Placental invasion is a potential life-threatening obstetric
condition that mandates a multidisciplinary approach for
appropriate management (10).
The greatest risk for placental invasion is previous cesarean
delivery and the presence of placenta previa. Other risk factors
include advanced maternal age and a history of uterine surgery
(11).
Prenatal diagnosis of placental invasion is necessary and
may be life saving. Ultrasound is the first line imaging modal-
ity; however, in equivocal cases, pelvic MRI is recommended
particularly when dealing with cases of posterior placenta (11).
The current research was a prospective study to determine
the role of MR imaging in the radiological diagnosis of cases
with placental abnormalities and diseases particularly cases
suspected to have placental invasion. In this study the sensitiv-
ity and specificity of US were 68% and 78.57% respectively
while those of MRI were 80% and 85.71% respectively in their
ability to diagnose placental invasion.
These findings are in agreement with several other studies
as Mansour and Elkhayat, Dwyer et al. and Masselli et al.
(5,12,13) and contradict those of Lam et al. (14). This contra-
diction may be because it was a retrospective study with a lim-
ited number of cases. Moreover, they did not make use of
color Doppler in this study and there were no recognized cri-
teria at that time for MRI diagnosis.
The sensitivity of the US and MRI is relatively lower in our
study which may be due to the number of false negative cases
Table 4 Sonographic findings in true-positive cases of placental invasion.
Patient Diagnosis Abnormal clear
space
Loss of bladder uterine
interface
Placental
lacunae
Hyper vascularity on color
Doppler
Decreased myometrial
thickness
1 Acc/Inc + +
2 Acc/Inc +
3 Acc/Inc + + +
4 Acc/Inc + +
5 Acc/Inc + + +
6 Acc/Inc + +
7 Acc/Inc + +
8 Acc/Inc + + +
9 Acc/Inc + +
10 Acc/Inc + +
11 Percreta + + +
12 Percreta + + + + +
13 Percreta + + + + +
14 Percreta + + + + +
15 Percreta + + + + +
16 Percreta + + + + +
17 Percreta + + + + +
Table 5 Sonographic findings in false-positive cases of placental invasion.
Patient Diagnosis Abnormal clear
space
Loss of bladder uterine
interface
Placental
lacunae
Hyper vascularity on color
Doppler
Decreased myometrial
thickness
1 Acc/Inc +
2 Acc/Inc + +
3 Acc/Inc + +
Table 6 MRI findings in true-positive cases of placental invasion.
Patient Diagnosis Uterine
bulging
Heterogeneous signal
intensity
Dark intraplacental
bands
Focal interruption in the
myometrium
Invasion of
surrounding
1 Acc/Inc +
2 Acc/Inc + + +
3 Acc/Inc + +
4 Acc/Inc + +
5 Acc/Inc + + +
6 Acc/Inc + + + +
7 Acc/Inc + + + +
8 Acc/Inc + +
9 Acc/Inc + + + +
10 Acc/Inc + + +
11 Acc/Inc + + + +
12 Acc/Inc + + + +
13 Acc/Inc + + +
14 Acc/Inc + + + +
15 Percreta + + + +
16 Percreta + + + + +
17 Percreta + + + + +
18 Percreta + + + + +
19 Percreta + + + + +
20 Percreta + + + + +
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due to either microinfiltration with no imaging changes
(Fig. 6), posterior placental location (Fig. 7), assessment at
early stage of gestation (25 and 28 weeks) or subtle changes
on imaging.The specificity of the US and MRI is relatively high in our
study and rather comparable to Mansour and Elkhayat results
which may be due to the fact that on US basis other authors
relied mainly upon abdominal US in their estimation yet in
our study as in Mansour and Elkhayat (5) study, we made
Table 7 MRI findings in false-positive cases of placental invasion.
Patient Diagnosis Uterine
bulging
Heterogeneous signal
intensity
Dark intraplacental
bands
Focal interruption in the
myometrium
Invasion of
surrounding
1 Acc/Inc +
2 Acc/Inc + + +
Table 8 Sonographic findings in proved cases of placental invasion (25 cases).
Item Abnormal clear
space
Loss of bladder uterine
interface
Placental
lacunae
Hyper vascularity on color
Doppler
Decreased myometrial
thickness
Number
sensitivity
17/25 6/25 14/25 6/25 12/25
68% 24% 56% 24% 48%
Table 9 MRI findings in proved cases of placental invasion (25 cases).
Item Uterine
bulging
Heterogeneous signal
intensity
Dark intraplacental
bands
Focal interruption in the
myometrium
Invasion of
surrounding
Number
sensitivity
12/25 20/25 18/25 16/25 6/25
48% 80% 72% 64% 24%
646 L.B. Hashem et al.use of transvaginal and/or translabial approach. Concerning
MRI, we also performed spin echo sequences with controlled
breath hold as in Mansour and Elkhayat (5) study. Such an
option provided images of better resolution and almost nil
motion artifacts from fetal body motion and maternal bowel
peristalsis and respiration.
MRI is less reliable in the differentiation between different
degrees of placental invasion, especially between accreta vera
and increta (15).
In this study, 9 cases were diagnosed as placenta percreta.
US correctly suggested the diagnosis of percreta in 6/9 cases
(66.67%) by interruption of the posterior bladder wall-
uterine interface and presence of hypervascularity of the inter-
face between uterine serosa and bladder wall on color Doppler.
MRI also correctly suggested the diagnosis of percreta in 6/9
(66.67%) cases where direct visualization of invasion of the
pelvis structures was seen in 6/9 (66.67%), with no tenting of
the urinary bladder noted in any of the cases 0/9 (0%).
US underestimated 2 cases of percreta and overestimated 1
case as percreta (Fig. 5), on the other side MRI underestimated
2 cases. Both modalities failed to diagnose a case of percretaTable 10 Sensitivity, specificity, PPV, NPV, PLR and NLR of
US and MRI in the diagnosis of placenta percreta.
Items US MRI
Sensitivity 66.67 66.67
Specificity 93.75 100.00
Positive predictive value 85.71 100.00
Negative predictive value 83.33 84.21
Accuracy 84.00 88.00
Positive likelihood ratio/95%
confidence interval
10.67/
1.51–75.2
Infinity/Nan-
infinity
Negative likelihood ratio/95%
confidence interval
0.36/0.14–
0.90
0.33/0.13–0.84posteriorly invading the fat between the uterus and rectum
(Fig. 7).
The US findings suggestive of placental invasion are loss of
the retroplacental hypoechoic clear zone, loss of the bladder
wall-uterine interface, presence of placental lacunae (vascular
spaces), and presence of hypervascularity of the interface
between the uterine serosa and the bladder wall on color Dop-
pler imaging (6 and 7).
In our study, obliteration of the retroplacental clear space
was found to have the highest sensitivity (68%) (Figs. 2–4), fol-
lowed by vascular lacunae (56%) (Fig. 5), decreased myome-
trial thickness (48%) (Figs. 2 and 3) and interruption of the
posterior bladder wall-uterine interface along with increased
vascularity on uterine interface between uterine serosa and
bladder wall (24%) (Fig. 3).
Different studies have emphasized on the signs of placental
invasion by US. Some concluded that visualization and num-
ber of lacunae have the highest sensitivity in the diagnosis of
invasion (78–93%) (6, 8 and 13), followed by obliteration of
the clear spaces (57%) and interruption of the posterior blad-
der–uterine wall interface (21%) (6). On the other hand,
Baughman et al. (8) found that loss of the retroplacental clear
space is often seen in normal pregnancies and does not con-
sider it a useful finding when seen alone. However, it is one
of the more obvious findings at screening evaluation and
should prompt a detailed evaluation for other US markers.
Derman et al. (11) also stated that the chaotic uteroplacental
vasculature may also be found in noninvasive placenta previa
because placenta previa is also associated with increased
vascularity.
Lax et al. (4) described the three secondary signs of abnor-
mal placentation on MRI: irregular thick intraplacental T2
dark bands, marked placental heterogeneity, and bulging of
the lower uterine segment. Other MRI findings suggestive of
placental invasion according to Baughman et al. (8) are focal
interruptions in the myometrial wall, tenting of the bladder,
Fig. 1 Placenta Previa Complete Centralis showing no features of invasion. Transabdominal US (a) gray-scale and (b) color Doppler
show homogenous placenta with normal vasculature, preserved retroplacental clear space and preserved myometrial thickness. MRI
images (c) Sagittal T2 (d) Coronal T1-weighted FSE show intact myometrium at the site of placental implantation (arrow in c). Placenta is
homogenous and of average thickness. Intact Interface between the uterine serosa and the urinary bladder. Operative and Pathological
findings: placenta previa with no evidence of adhesion to the myometrium.
Role of MRI versus ultrasound 647and direct visualization of the invasion of pelvic structures by
placental tissue.
In concordance with the findings of Lax et al., we also
found that the abnormal heterogeneous signal intensity of
the placenta was seen in 80%, dark intra placenta bands on
T2 sequences were seen in 72% and bulging of the lower uter-
ine segment was seen in 48% of the surgically/pathologically
proved cases of placenta accreta.
In our study we evaluated the individual ability of MR
imaging and Ultrasound to predict placental invasion in the
same group of cases.
Matching between US and MRI findings took place in
78.57% (n= 11/14) of the negative cases and in 68%(n= 17/25) of the positive cases of placenta accreta in our
work. MRI and US had matched diagnosis regardless of the
outcome in 71.79% (n= 28/39) and mismatching took place
in 28%.
When there is a mismatch between ultrasound and MRI
diagnosis, it is probably better to consider that the more
aggressive findings are correct. False positive imaging results
(Fig. 8) are less harmful to the patient because the obstetrician
will be prepared for the possibility of hysterectomy and (if
percreta with invasion) bladder/rectum resection rather than
be subjected to such possibilities with no preparation.
Our study also included one case with cesarean scar ectopic
pregnancy which was diagnosed by both US and MRI. The
Fig. 2 Placenta previa complete centralis. Transabdominal US (a) gray-scale and (b) color Doppler show the placenta extending to the
serosal surface of the bladder without any intervening myometrium (arrow in a) and interrupted postplacental vasculature with a
suspected crossing vasculature from uterine serosa to the bladder (arrow in b). Translabial US color Doppler image (c) shows no crossing
vessels detected. B = Bladder, P = Placenta. Impression: Placenta increta. MRI images (d) Sagittal T2 and (e) Sagittal T1-weighted FSE
images show thickened and macrolobulated placenta with placental lacunae. Evidence of infiltration of inner layer of the myometrium in
the lower uterine segment anteriorly (arrow in d). Clear fat plane is noted (arrow in e). Impression: Placenta increta. Operative findings
and Pathology revealed Increta.
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Fig. 3 Placenta previa complete centralis. Transabdominal US (a) gray-scale and (b) color Doppler show heterogenous placenta
extending to the serosal surface of the bladder without any intervening myometrium, vascular lacunae and increased vascularity on the
interface with crossing vessels to the bladder (arrow in b). B = Bladder, P = Placenta. Impression: Placenta percreta. MRI images (c)
Sagittal T2 and (d) Coronal T1-weighted FSE show thickened, heterogeneous placenta with markedly thinned and interrupted
myometrium (arrow in c), uterine bulge with irregular outline and no intervening fat planes between urinary bladder and placenta (arrow
in d). Impression: Percreta. Post operative hysterectomy specimen (e) show uterine bulge with the placenta reaching the serosal surface of
the uterus with no invasion of the urinary bladder (Placenta percreta). Operative and pathological findings: Placenta percreta.
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Fig. 4 Placenta Previa Complete Centralis. Transabdominal US (a) gray-scale and (b) power Doppler show thinned out myometrium
with loss of retroplacental clear space and interrupted retroplacental vascular bed (arrows) suggesting placenta accreta. MRI images (c)
Sagittal T2 (d) Coronal T2 (e) Sagittal T1-weighted FSE show uterine bulging of the lower uterine segment altering the normal pear shape
of the gravid uterus, thickened inhomogeneous placenta infiltrating the inner layer of the myometrium at lower uterine segment (arrow in
c). Note dark intraplacental band. Intact interface between the uterine serosa and urinary bladder. (Site of previous CS can be seen with
fat anteriorly <arrow head>). Impression: Placenta increta. Operative findings and Pathology: Placenta Accreta.
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Fig. 5 Placenta Previa Complete Centralis. Transabdominal US (a) gray-scale and (b) power Doppler show heterogenous placenta with
hypoechoic vascular spaces representing placental lacunae giving the characteristic ‘‘Swiss cheese appearance”. Note the hypervascularity
of the interface between the uterine serosa and the bladder wall (arrows in b). B = Bladder, P = Placenta. Impression: Placenta percreta.
MRI images (c) Sagittal T2 (d) Sagittal T1-weighted FSE show placental signs of invasion: Thickened, nodular outline of the uterus,
placental lacunae, intraplacental dark bands and infiltration of the whole myometrial bulk anteriorly and to the left at the presumed site of
previous CS (arrow in c). Intact interface between uterine serosa and bladder anteriorly (arrow in d) and rectum posteriorly. Impression:
Placenta increta. Operative findings and Pathology: Placenta increta.
Role of MRI versus ultrasound 651hallmark of diagnosis was a low implanted fetus at the site of
previous cesarean scar together with an empty uterine cavity
and closed internal os. Placental invasion disorder was also
noted on MRI.
We diagnosed 10 other cases with placental abnormalities
and diseases other than abnormal placental location and/or
implantation.Placental abruption is characterized as the premature
detachment of the placenta from its implantation site and its
diagnosis is clinical (16). Typically, unless a secondary sign,
such as a hematoma, is large enough to detect, it is not evident
ultrasonographically. MRI has superior sensitivity for detec-
tion of abruption compared to US (100% versus 53%) (17).
In this study, we had 2 cases with placental hematoma and
abruption. By US one was indeterminate and was suspected to
Fig. 6 Placenta previa complete centralis. Transabdominal US (a) color Doppler show no features of accreta with homogenous placenta
and normal vasculature. Impression: Normal. MRI images (b) Coronal T2 (c) Sagittal T2 and (d) Coronal T1-weighted FSE show
homogenous placenta of average thickness, intact myometrium (arrow in b) at site of implantation with no dark bands or placental
lacunae. Intact interface between uterine serosa and urinary bladder (arrow in d). Impression: Normal. Operative findings: The placenta
was separated during labor; however, massive bleeding occurred so hysterectomy was done. Pathology revealed mature placental tissue
infiltrating not perforating the myometrium (placenta accreta).
652 L.B. Hashem et al.be a placental mass (Fig. 11) while the other was correctly
diagnosed by US. However, MRI with its superior sensitivity
and specificity confirmed the diagnosis of placental hematoma
in the two cases due to the presence of blood signal intensity in
the images.
Concerning gestational trophoblastic disease (GTD), the
radiologist plays an important role in the initial diagnosis,
guiding disease management and early detection of its compli-
cations. Ultrasound is the first imaging modality of choice in
confirming the diagnosis of GTD in a case suspected on the
basis of clinical findings and b-HCG levels. Doppler is also
useful for diagnosing invasive disease, assessing treatmentresponse, and detecting local recurrence because of the hyper-
vascular nature of these tumors, although this is not always
detectable (18).
MRI is not frequently used in the evaluation of molar preg-
nancies, because of the nonspecific imaging findings that coin-
cide with retained products of conception. However, it can
have a role in demonstrating myometrial and parametrial inva-
sion (1).
MRI and Doppler Ultrasound are complementary investi-
gations in patients with GTD. Tumor vascularity is better
assessed with Doppler US while tumor extension is better
assessed with MRI (19).
Fig. 7 Placenta previa complete centralis. Transabdominal US (a) gray-scale and (b) color Doppler show no abnormality, normal
placental thickness, homogenous texture with no interruption in the retroplacental vascularity. MRI images (c) Sagittal T2, (d) Coronal
T1 and (e) Coronal T2-weighted FSE were reported as normal since the placenta appeared homogenous and of average thickness;
however, rereading them shows uterine bulge with disruption of the myometrium posteriorly (white arrow in c) and the normally
continuous low signal intensity bladder dome (arrows in e) with increased vascularity around the uterus posteriorly (black arrow in c)
(signal void vessels). Operative findings and Pathology: Placental invasion with percreta found posteriorly and increta anteriorly.
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Fig. 8 US images are not available; however, no abnormality was detected. MRI images (a–d) Sagittal T2-weighted FSE were viewed by
the 1st radiologist who reported normal (normal thickness of the placental with no interruption of the myometrium and clear fat plane
between the uterus and the bladder) while the 2nd radiologist suspected posterior invasion (suspected focal myometrial disruption in a and
b (arrows) posteriorly since there is no definite fat plane between the uterus and the rectum), so the higher diagnosis was suggested.
Impression: Placenta percreta posteriorly. Operative findings and Pathology: Placenta Previa with no evidence of adhesion to the
myometrium.
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Fig. 9 Partial Vesicular mole. US images (a) Transabdominal Gray-scale, (b) Transvaginal power Doppler, (c) and Transabdominal
power Doppler show a well defined echogenic mass with multiple cystic spaces and preserved myometrial vascularity. Note the empty
gestational sac (GS and arrows in b). MRI images (d) Sagittal T2, (e) Sagittal T1 and (f) Sagittal T1-weighted FSE post contrast show
multiple cystic structures with no invasion of the myometrium (arrow in f). Note the empty gestational sac (arrow in e). Operative findings
and Pathology: Curettage was done and pathology revealed partial vesicular mole. Follow-up bHCG level declined.
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Fig. 10 A 35 year-old female patient with history of complete abortion at the 2nd month of pregnancy followed by repeated dilatation
and curettage complaining of continuous vaginal bleeding. US Images are not available. Uterine cavity showed a mass remnant of vesicular
mole 2.9  4.2 cm with preservation of uterine wall. Normal ovaries. MRI images (a) Sagittal T2, (b) Sagittal T1, (c and d) Coronal T1-
weighted FSE post contrast show an ill-defined heterogenous mass lesion of mixed signal intensity showing heterogenous enhancement. It
is seen disrupting the junctional zone with evidence of myometrial invasion at the right superolateral aspect (arrows in a and b). Right
adnexal thin walled cystic lesion (arrow in d) measuring about 20  15 mm. Operative findings and Pathology: Gestational trophoblastic
disease (invasive mole). She received chemotherapy and follow-up bHCG level declined after chemotherapy.
656 L.B. Hashem et al.In our study we had 8 cases with gestational trophoblastic
disease (4 vesicular mole and 4 invasive mole/choriocarci-
noma). One of the invasive mole/choriocarcinoma cases was
misdiagnosed by US as vesicular mole; however, MRI revealed
myometrial invasion that helped to correctly diagnose it
(Fig. 10). The rest of cases (n= 7/8) were correctly diagnosed
by both modalities (Fig. 9).
The limitation of our study is that we had a relatively small
sample size and given the rarity of placental abnormalities and
diseases; a large sample group was difficult to gather.5. Conclusion
Our results showed that MRI is a complementary imaging
modality and problem solving method especially with equivo-
cal ultrasound or Doppler examination and when further char-
acterization is required, particularly in the setting of invasive
placental processes such as placenta implantation abnormali-
ties (placenta accreta, percreta and increta) and gestational
trophoblastic disease which results in modifications of surgical
techniques, allowing a reduction in historical morbidity.
Fig. 11 US images (a and b) Transabdominal power Doppler and (c) 3D Transabdominal US show a homogeneous well defined mass
with suspected faint vascularity suggestive of placental mass. Note the displaced umbilical cord (arrow in b) and the fetus (arrow in c).
MRI images (d) Sagittal T2 and (e) Sagittal T1-weighted FSE show a large hematoma mostly replacing the placenta eliciting
heterogeneous texture with fluid fluid level and foci of high T1 signal (arrow in e). Operative findings and Pathology: Miscarriage occurred
followed by dilatation and curettage (placental hematoma).
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